Emerging role of Fatty acid synthase in tumor initiation: implications for cancer prevention
Targeting metabolic reprogramming has emerged as a promising strategy for therapeutic intervention in cancer. We identify that fatty acid synthase (FASN) is essential for cancer initiation playing a critical role in acquiring three-dimensional (3D) growth properties during transformation. In vivo in...
Saved in:
Published in: | Molecular & cellular oncology Vol. 7; no. 2; p. 1709389 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Taylor & Francis
03-03-2020
Taylor & Francis Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Targeting metabolic reprogramming has emerged as a promising strategy for therapeutic intervention in cancer. We identify that fatty acid synthase (FASN) is essential for cancer initiation playing a critical role in acquiring three-dimensional (3D) growth properties during transformation. In vivo inhibition of FASN before oncogenic activation prevents tumor development and invasive growth suggesting that FASN could be a potential target for cancer prevention. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2372-3556 2372-3556 |
DOI: | 10.1080/23723556.2019.1709389 |